Schaefer K U, Schoone G J, Gachihi G S, Muller A S, Kager P A, Meredith S E
Department of Infectious Diseases, University of Amsterdam, The Netherlands.
Trans R Soc Trop Med Hyg. 1995 Sep-Oct;89(5):492-5. doi: 10.1016/0035-9203(95)90081-0.
The polymerase chain reaction was applied to capillary blood spots dried on filter paper from 20 parasitologically proved cases of visceral leishmaniasis (VL), 21 subclinical cases, and 11 healthy controls in a longitudinal study of anthroponotic VL in Baringo District, Kenya. Leishmania deoxyribonucleic acid (DNA) was detected 10.5 months before diagnosis and up to 3 years after diagnosis and apparently successful treatment. Subclinical cases can have detectable circulating parasite DNA in their blood. These findings may indicate that subclinical cases can be a reservoir and formerly treated VL patients can remain a reservoir for a long time. Xenodiagnosis should be performed on subclinical cases and former VL patients to establish their role in transmission of VL in Kenya.
在肯尼亚巴林戈区对人源型内脏利什曼病(VL)进行的一项纵向研究中,聚合酶链反应应用于从20例经寄生虫学证实的VL病例、21例亚临床病例和11名健康对照者的滤纸干血斑样本。在诊断前10.5个月以及诊断后直至3年且经明显成功治疗后,均可检测到利什曼原虫脱氧核糖核酸(DNA)。亚临床病例血液中可检测到循环的寄生虫DNA。这些发现可能表明,亚临床病例可能是一个储存宿主,而且既往接受过治疗的VL患者可能长期仍是储存宿主。应对亚临床病例和既往VL患者进行接种诊断,以确定其在肯尼亚VL传播中的作用。